Does Diabetes Always Confer Coronary Heart Disease Risk Equivalent to a Prior Myocardial Infarction? Implications for prevention

被引：12
作者：
Boyko, Edward J. [1 ,2 ]
Meigs, James B. [3 ]
机构：
[1] VA Puget Sound Hlth Care Syst, Seattle Epidemiol Res & Informat Ctr, Seattle, WA USA
[2] Univ Washington, Dept Med, Seattle, WA 98195 USA
[3] Harvard Univ, Sch Med, Div Gen Med, Boston, MA USA
来源：
DIABETES CARE | 2011年 / 34卷 / 03期
关键词：
SCIENTIFIC STATEMENT; TYPE-2; INTERVENTION; ASSOCIATION; ASPIRIN; PEOPLE;
D O I：
10.2337/dc10-1958
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：782 / 784
页数：3
相关论文
共 17 条
[1]   Is diabetes a coronary risk equivalent? Systematic review and meta-analysis [J].
Bulugahapitiya, U. ;
Siyambalapitiya, S. ;
Sithole, J. ;
Idris, I. .
DIABETIC MEDICINE, 2009, 26 (02) :142-148
[2]   Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study [J].
Burgess, David C. ;
Hunt, David ;
Li, LiPing ;
Zannino, Diana ;
Williamson, Elizabeth ;
Davis, Timothy M. E. ;
Laakso, Markku ;
Kesaniemi, Y. Antero ;
Zhang, Jun ;
Sy, Raymond W. ;
Lehto, Seppo ;
Mann, Stewart ;
Keech, Anthony C. .
EUROPEAN HEART JOURNAL, 2010, 31 (01) :92-99
[3]  
Buse JB, 2007, DIABETES CARE, V30, P162, DOI [10.2337/dc07-9917, 10.1161/CIRCULATIONAHA.106.179294]
[4]   What's more dangerous, your aspirin or your car? Thinking rationally about drug risks (and benefits) [J].
Cohen, Joshua T. ;
Neumann, Peter J. .
HEALTH AFFAIRS, 2007, 26 (03) :636-646
[5]  
Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1
[6]   Presenting risk information - A review of the effects of "framing'' and other manipulations on patient outcomes [J].
Edwards, A ;
Elwyn, G ;
Covey, J ;
Matthews, E ;
Pill, R .
JOURNAL OF HEALTH COMMUNICATION, 2001, 6 (01) :61-82
[7]   Long-Term Cardiovascular Risk in Type 2 Diabetic Compared With Nondiabetic First Acute Myocardial Infarction Patients A population-based cohort study in southern Europe [J].
Francisco Cano, J. ;
Baena-Diez, Jose M. ;
Franch, Josep ;
Vila, Joan ;
Tello, Susana ;
Sala, Joan ;
Elosua, Roberto ;
Marrugat, Jaume .
DIABETES CARE, 2010, 33 (09) :2004-2009
[8]   Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction [J].
Haffner, SM ;
Lehto, S ;
Rönnemaa, T ;
Pyörälä, K ;
Laakso, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (04) :229-234
[9]   10-year follow-up of intensive glucose control in type 2 diabetes [J].
Holman, Rury R. ;
Paul, Sanjoy K. ;
Bethel, M. Angelyn ;
Matthews, David R. ;
Neil, H. Andrew W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (15) :1577-1589
[10]   Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine [J].
Kalow, W. .
PHARMACOGENOMICS JOURNAL, 2006, 6 (03) :162-165
12